首页 > 最新文献

Minerva cardioangiologica最新文献

英文 中文
Mapping decision making for bypass surgery in the era of interventional medicine: towards an integrative model of patient-centeredness. 介入医学时代搭桥手术的绘图决策:迈向以患者为中心的整合模式。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-07-10 DOI: 10.23736/S0026-4725.20.05228-7
Milan Milojevic, Petar Milacic, Ivana Petrovic, Milovan Bojic, Aleksandar Milojevic, Aleksandar Nikolic, Sigrid Sandner, Miguel Sousa-Uva

This article reviews the context and evidence of recent myocardial revascularization trials on PCI versus CABG with particular emphasis on patient selection and treatment of surgical patients. Moreover, one of our intended purposes is to identify the values underpinning the integrated care model, which incorporates decision to proceed with surgical myocardial revascularization in conjunction with established pillars of the use of optimal surgical techniques, and aggressive risk-factor modification through guideline-directed pharmacological therapies and lifestyle modifications.

本文回顾了最近的PCI与CABG心肌血运重建试验的背景和证据,特别强调了手术患者的选择和治疗。此外,我们的预期目的之一是确定支撑综合护理模式的价值,其中包括决定进行外科心肌血运重建术,结合使用最佳手术技术的既定支柱,以及通过指导的药物治疗和生活方式改变积极的风险因素。
{"title":"Mapping decision making for bypass surgery in the era of interventional medicine: towards an integrative model of patient-centeredness.","authors":"Milan Milojevic,&nbsp;Petar Milacic,&nbsp;Ivana Petrovic,&nbsp;Milovan Bojic,&nbsp;Aleksandar Milojevic,&nbsp;Aleksandar Nikolic,&nbsp;Sigrid Sandner,&nbsp;Miguel Sousa-Uva","doi":"10.23736/S0026-4725.20.05228-7","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05228-7","url":null,"abstract":"<p><p>This article reviews the context and evidence of recent myocardial revascularization trials on PCI versus CABG with particular emphasis on patient selection and treatment of surgical patients. Moreover, one of our intended purposes is to identify the values underpinning the integrated care model, which incorporates decision to proceed with surgical myocardial revascularization in conjunction with established pillars of the use of optimal surgical techniques, and aggressive risk-factor modification through guideline-directed pharmacological therapies and lifestyle modifications.</p>","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"469-479"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38148048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Myocardial revascularization in chronic coronary syndromes: does viability matter? 慢性冠状动脉综合征的心肌血运重建术:生存能力重要吗?
Q3 Medicine Pub Date : 2020-10-01 DOI: 10.23736/S0026-4725.20.05312-8
Alessandra Scatteia, Anna Baritussio, Chiara Bucciarelli-Ducci

Coronary artery disease (CAD) is the leading cause of death worldwide and improving the prognosis and survival of patients with ischemic heart disease remains a priority of cardiovascular specialists. This article will review the principles of myocardial viability, present the noninvasive imaging tests available to clinicians, as well as critically appraise the latest literature on myocardial viability, coronary revascularization and outcome with a final outlook at studies in the pipelines and future evidence in myocardial viability that will be soon available.

冠状动脉疾病(CAD)是世界范围内死亡的主要原因,改善缺血性心脏病患者的预后和生存率仍然是心血管专家的首要任务。本文将回顾心肌活力的原理,介绍临床医生可用的无创成像检查,并对心肌活力、冠状动脉血运重建术和结果的最新文献进行批判性评价,最后展望在管道中的研究和即将获得的心肌活力的未来证据。
{"title":"Myocardial revascularization in chronic coronary syndromes: does viability matter?","authors":"Alessandra Scatteia,&nbsp;Anna Baritussio,&nbsp;Chiara Bucciarelli-Ducci","doi":"10.23736/S0026-4725.20.05312-8","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05312-8","url":null,"abstract":"<p><p>Coronary artery disease (CAD) is the leading cause of death worldwide and improving the prognosis and survival of patients with ischemic heart disease remains a priority of cardiovascular specialists. This article will review the principles of myocardial viability, present the noninvasive imaging tests available to clinicians, as well as critically appraise the latest literature on myocardial viability, coronary revascularization and outcome with a final outlook at studies in the pipelines and future evidence in myocardial viability that will be soon available.</p>","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"386-392"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38573432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Artificial intelligence in cardiothoracic surgery. 人工智能在心胸外科的应用。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-09-29 DOI: 10.23736/S0026-4725.20.05235-4
Roger D Dias, Julie A Shah, Marco A Zenati

The tremendous and rapid technological advances that humans have achieved in the last decade have definitely impacted how surgical tasks are performed in the operating room (OR). As a high-tech work environment, the contemporary OR has incorporated novel computational systems into the clinical workflow, aiming to optimize processes and support the surgical team. Artificial intelligence (AI) is increasingly important for surgical decision making to help address diverse sources of information, such as patient risk factors, anatomy, disease natural history, patient values and cost, and assist surgeons and patients to make better predictions regarding the consequences of surgical decisions. In this review, we discuss the current initiatives that are using AI in cardiothoracic surgery and surgical care in general. We also address the future of AI and how high-tech ORs will leverage human-machine teaming to optimize performance and enhance patient safety.

人类在过去十年中取得的巨大而快速的技术进步无疑影响了手术室(OR)中外科手术任务的执行方式。作为一种高科技工作环境,当代手术室已将新型计算系统纳入临床工作流程,旨在优化流程并为手术团队提供支持。人工智能(AI)对手术决策的重要性与日俱增,它可以帮助处理各种信息来源,如患者风险因素、解剖结构、疾病自然史、患者价值观和成本,并帮助外科医生和患者更好地预测手术决策的后果。在这篇综述中,我们将讨论目前将人工智能应用于心胸外科手术和外科护理的总体举措。我们还探讨了人工智能的未来,以及高科技手术室将如何利用人机协作来优化性能和提高患者安全。
{"title":"Artificial intelligence in cardiothoracic surgery.","authors":"Roger D Dias, Julie A Shah, Marco A Zenati","doi":"10.23736/S0026-4725.20.05235-4","DOIUrl":"10.23736/S0026-4725.20.05235-4","url":null,"abstract":"<p><p>The tremendous and rapid technological advances that humans have achieved in the last decade have definitely impacted how surgical tasks are performed in the operating room (OR). As a high-tech work environment, the contemporary OR has incorporated novel computational systems into the clinical workflow, aiming to optimize processes and support the surgical team. Artificial intelligence (AI) is increasingly important for surgical decision making to help address diverse sources of information, such as patient risk factors, anatomy, disease natural history, patient values and cost, and assist surgeons and patients to make better predictions regarding the consequences of surgical decisions. In this review, we discuss the current initiatives that are using AI in cardiothoracic surgery and surgical care in general. We also address the future of AI and how high-tech ORs will leverage human-machine teaming to optimize performance and enhance patient safety.</p>","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"532-538"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959017/pdf/nihms-1658490.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38431251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thoracic aortic surgery: status and upcoming novelties. 胸主动脉手术:现状和即将到来的新事物。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-04-21 DOI: 10.23736/S0026-4725.20.05263-9
Cristiano Spadaccio, Haiou Hu, Chengnan Li, Zhiyu Qiao, Yipeng Ge, Zheng Tie, Junming Zhu, Marc R Moon, Mark Danton, Lizhong Sun, Mario F Gaudino

Several novel technological developments and surgical approaches have characterized the field of aortic surgery in the recent decade. The progressive introduction of endovascular procedures, minimally invasive surgical techniques and hybrid approaches have changed the practice in aortic surgery and generated new trends and questions. Also, the advancements in the manufacturing of tissue engineered vascular grafts as substitutes for aortic replacements are enlightening new avenues in the treatment of aortic disease. This review will provide an overview of the current novel perspectives, debates and trends in major thoracic aortic surgery.

近十年来,一些新的技术发展和手术方法成为主动脉外科手术领域的特点。血管内手术、微创手术技术和混合入路的逐步引入改变了主动脉手术的实践,并产生了新的趋势和问题。此外,组织工程血管移植物作为主动脉置换替代物的制造进展也为主动脉疾病的治疗开辟了新的途径。本文综述了当前胸主动脉外科手术的新观点、争论和发展趋势。
{"title":"Thoracic aortic surgery: status and upcoming novelties.","authors":"Cristiano Spadaccio,&nbsp;Haiou Hu,&nbsp;Chengnan Li,&nbsp;Zhiyu Qiao,&nbsp;Yipeng Ge,&nbsp;Zheng Tie,&nbsp;Junming Zhu,&nbsp;Marc R Moon,&nbsp;Mark Danton,&nbsp;Lizhong Sun,&nbsp;Mario F Gaudino","doi":"10.23736/S0026-4725.20.05263-9","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05263-9","url":null,"abstract":"<p><p>Several novel technological developments and surgical approaches have characterized the field of aortic surgery in the recent decade. The progressive introduction of endovascular procedures, minimally invasive surgical techniques and hybrid approaches have changed the practice in aortic surgery and generated new trends and questions. Also, the advancements in the manufacturing of tissue engineered vascular grafts as substitutes for aortic replacements are enlightening new avenues in the treatment of aortic disease. This review will provide an overview of the current novel perspectives, debates and trends in major thoracic aortic surgery.</p>","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"518-531"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37859988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Endothelial damage inhibitors for improvement of saphenous vein graft patency in coronary artery bypass grafting. 内皮损伤抑制剂改善冠状动脉旁路移植术中隐静脉通畅。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-04-23 DOI: 10.23736/S0026-4725.20.05234-2
Sigrid E Sandner, Catherine J Pachuk, Thomas Aschacher, Milan Milojevic, Etem Caliskan, Maximilian Y Emmert

The saphenous vein graft (SVG) remains the most commonly used conduit in coronary artery bypass grafting (CABG). In light of this further research must be aimed at the development of strategies to optimize SVG patency and thereby improve both short- and long-term outcomes of CABG surgery. SVG patency in large part depends on the protection of the structural and functional integrity of the vascular endothelium at the time of conduit harvesting, including optimal storage conditions to prevent endothelial damage. This review provides an overview of currently available storage and preservation solutions, including novel endothelial damage inhibitors, and their role in mitigating endothelial damage and vein graft failure.

隐静脉移植物(SVG)仍然是冠状动脉旁路移植术(CABG)中最常用的导管。鉴于此,进一步的研究必须旨在制定优化SVG通畅的策略,从而改善CABG手术的短期和长期结果。SVG的通畅在很大程度上取决于导管收集时对血管内皮结构和功能完整性的保护,包括最佳的储存条件以防止内皮损伤。本文综述了目前可用的储存和保存方法,包括新型内皮损伤抑制剂,以及它们在减轻内皮损伤和静脉移植衰竭中的作用。
{"title":"Endothelial damage inhibitors for improvement of saphenous vein graft patency in coronary artery bypass grafting.","authors":"Sigrid E Sandner,&nbsp;Catherine J Pachuk,&nbsp;Thomas Aschacher,&nbsp;Milan Milojevic,&nbsp;Etem Caliskan,&nbsp;Maximilian Y Emmert","doi":"10.23736/S0026-4725.20.05234-2","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05234-2","url":null,"abstract":"<p><p>The saphenous vein graft (SVG) remains the most commonly used conduit in coronary artery bypass grafting (CABG). In light of this further research must be aimed at the development of strategies to optimize SVG patency and thereby improve both short- and long-term outcomes of CABG surgery. SVG patency in large part depends on the protection of the structural and functional integrity of the vascular endothelium at the time of conduit harvesting, including optimal storage conditions to prevent endothelial damage. This review provides an overview of currently available storage and preservation solutions, including novel endothelial damage inhibitors, and their role in mitigating endothelial damage and vein graft failure.</p>","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"480-488"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37865339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Left ventricular global longitudinal strain and cardiac surgical outcomes. 左心室整体纵向应变与心脏手术结果。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-05-29 DOI: 10.23736/S0026-4725.20.05251-2
Lisa Q Rong, Peter J Neuburger, Jiwon Kim, Richard B Devereux

Global longitudinal strain (GLS) has emerged as a valuable diagnostic and prognostic tool for evaluating left ventricular (LV) function. GLS has been shown to be a more sensitive marker of LV dysfunction than LV ejection fraction alone and have prognostic impact in non-surgical cardiac populations. GLS, is validated, reproducible, and easily obtained from 2-dimensional speckle-tracking echocardiography. While there is strong evidence for using GLS in clinical decision-making in non-surgical populations, there is less summarized evidence on using GLS in the cardiac surgical population. This review combines the evidence on the implications of using baseline transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) GLS in cardiac surgical populations including ischemic and structural heart disease to determine surgical outcomes. We found that results seem promising on the prognostic utility of LV strain in cardiac surgical populations. However due to the variability of study populations and outcomes, and modalities (TTE versus TEE), further research on normal versus abnormal values for different surgical populations, as well potential treatment options that may modify and potentially decrease surgical risk for those with abnormal GLS are needed.

整体纵向应变(GLS)已成为评估左室(LV)功能的有价值的诊断和预后工具。GLS已被证明是比单独左室射血分数更敏感的左室功能障碍标志物,并对非手术心脏人群的预后有影响。GLS是经过验证的,可重复的,并且很容易从二维斑点跟踪超声心动图中获得。虽然有强有力的证据表明在非手术人群的临床决策中使用GLS,但在心脏手术人群中使用GLS的总结证据较少。本综述结合了使用基线经胸超声心动图(TTE)和经食管超声心动图(TEE) GLS在心脏手术人群(包括缺血性和结构性心脏病)中确定手术结果的证据。我们发现,在心脏外科人群中,左室毒株的预后应用结果似乎很有希望。然而,由于研究人群、结果和方式(TTE与TEE)的可变性,需要进一步研究不同手术人群的正常与异常值,以及可能改变和潜在降低异常GLS患者手术风险的潜在治疗方案。
{"title":"Left ventricular global longitudinal strain and cardiac surgical outcomes.","authors":"Lisa Q Rong,&nbsp;Peter J Neuburger,&nbsp;Jiwon Kim,&nbsp;Richard B Devereux","doi":"10.23736/S0026-4725.20.05251-2","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05251-2","url":null,"abstract":"<p><p>Global longitudinal strain (GLS) has emerged as a valuable diagnostic and prognostic tool for evaluating left ventricular (LV) function. GLS has been shown to be a more sensitive marker of LV dysfunction than LV ejection fraction alone and have prognostic impact in non-surgical cardiac populations. GLS, is validated, reproducible, and easily obtained from 2-dimensional speckle-tracking echocardiography. While there is strong evidence for using GLS in clinical decision-making in non-surgical populations, there is less summarized evidence on using GLS in the cardiac surgical population. This review combines the evidence on the implications of using baseline transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) GLS in cardiac surgical populations including ischemic and structural heart disease to determine surgical outcomes. We found that results seem promising on the prognostic utility of LV strain in cardiac surgical populations. However due to the variability of study populations and outcomes, and modalities (TTE versus TEE), further research on normal versus abnormal values for different surgical populations, as well potential treatment options that may modify and potentially decrease surgical risk for those with abnormal GLS are needed.</p>","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"489-496"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37988972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Performing a PCI through a trifurcated aortic graft: a new challenging access route. 通过三瓣主动脉移植物行PCI:一种新的具有挑战性的通路。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-06-10 DOI: 10.23736/S0026-4725.20.05258-5
Gregorio Menzà, Fabrizio D'Ascenzo, Matteo Attisani, Michele La Torre, Fabio Verzini, Mauro Rinaldi, Gaetano M De Ferrari
{"title":"Performing a PCI through a trifurcated aortic graft: a new challenging access route.","authors":"Gregorio Menzà,&nbsp;Fabrizio D'Ascenzo,&nbsp;Matteo Attisani,&nbsp;Michele La Torre,&nbsp;Fabio Verzini,&nbsp;Mauro Rinaldi,&nbsp;Gaetano M De Ferrari","doi":"10.23736/S0026-4725.20.05258-5","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05258-5","url":null,"abstract":"","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"373-375"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38032971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novelties in cardiac surgery: an introduction. 心脏外科的新进展:导论。
Q3 Medicine Pub Date : 2020-10-01 Epub Date: 2020-05-29 DOI: 10.23736/S0026-4725.20.05324-4
N Bryce Robinson, Mario F Gaudino
{"title":"Novelties in cardiac surgery: an introduction.","authors":"N Bryce Robinson,&nbsp;Mario F Gaudino","doi":"10.23736/S0026-4725.20.05324-4","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05324-4","url":null,"abstract":"","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"68 5","pages":"451-452"},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37988452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine. 解开心血管患者的表观遗传景观:通往个性化医疗的道路。
Q3 Medicine Pub Date : 2020-09-30 DOI: 10.23736/S0026-4725.20.05326-8
S. Ambrosini, S. Mohammed, S. Costantino, F. Paneni
Despite significant advances in our understanding of cardiovascular disease (CVD) we are still far from having developed breakthrough strategies to combat coronary atherosclerosis and heart failure, which account for most of CV deaths worldwide. Available cardiovascular therapies have failed to show to be equally effective in all patients, suggesting that interindividual diversity is an important factor when it comes to conceive and deliver effective personalized treatments. Genome mapping has proved useful in identifying patients who could benefit more from specific drugs depending on genetic variances; however, our genetic make-up determines only a limited part of an individual's risk profile. Recent studies have demonstrated that epigenetic changes - defined as dynamic changes of DNA and histones which do not affect DNA sequence - are key players in the pathophysiology of cardiovascular disease and may participate to delineate cardiovascular risk trajectories over the lifetime. Epigenetic modifications include changes in DNA methylation, histone modifications and non-coding RNAs and these epigenetic signals have shown to cooperate in modulating chromatin accessibility to transcription factors and gene expression. Environmental factors such as air pollution, smoking, psychosocial context and unhealthy diet regimens have shown to significantly modify the epigenome thus leading to altered transcriptional programs and CVD phenotypes. Therefore, the integration of genetic and epigenetic information might be invaluable to build individual maps of cardiovascular risk and hence, could be employed for the design of customized diagnostic and therapeutic strategies. In the present review, we discuss the growing importance of epigenetic information and its putative implications in cardiovascular precision medicine.
尽管我们对心血管疾病(CVD)的了解取得了重大进展,但我们仍远未开发出突破性的策略来对抗冠状动脉粥样硬化和心力衰竭,这两种疾病占全球心血管死亡的大部分。现有的心血管治疗方法并不能对所有患者都同样有效,这表明在构思和提供有效的个性化治疗时,个体间的多样性是一个重要因素。基因组图谱已被证明在确定哪些患者可以根据遗传差异从特定药物中获益更多方面是有用的;然而,我们的基因构成只决定了个人风险概况的有限部分。最近的研究表明,表观遗传变化-定义为DNA和组蛋白不影响DNA序列的动态变化-在心血管疾病的病理生理中起着关键作用,并可能参与描述一生中心血管风险轨迹。表观遗传修饰包括DNA甲基化、组蛋白修饰和非编码rna的变化,这些表观遗传信号已被证明在调节染色质对转录因子和基因表达的可及性方面相互合作。环境因素,如空气污染、吸烟、社会心理环境和不健康的饮食方案,已被证明会显著改变表观基因组,从而导致转录程序和心血管疾病表型的改变。因此,遗传和表观遗传信息的整合对于建立心血管风险的个体地图可能是无价的,因此,可以用于定制诊断和治疗策略的设计。在这篇综述中,我们讨论了表观遗传信息在心血管精准医学中的重要性及其可能的意义。
{"title":"Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine.","authors":"S. Ambrosini, S. Mohammed, S. Costantino, F. Paneni","doi":"10.23736/S0026-4725.20.05326-8","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05326-8","url":null,"abstract":"Despite significant advances in our understanding of cardiovascular disease (CVD) we are still far from having developed breakthrough strategies to combat coronary atherosclerosis and heart failure, which account for most of CV deaths worldwide. Available cardiovascular therapies have failed to show to be equally effective in all patients, suggesting that interindividual diversity is an important factor when it comes to conceive and deliver effective personalized treatments. Genome mapping has proved useful in identifying patients who could benefit more from specific drugs depending on genetic variances; however, our genetic make-up determines only a limited part of an individual's risk profile. Recent studies have demonstrated that epigenetic changes - defined as dynamic changes of DNA and histones which do not affect DNA sequence - are key players in the pathophysiology of cardiovascular disease and may participate to delineate cardiovascular risk trajectories over the lifetime. Epigenetic modifications include changes in DNA methylation, histone modifications and non-coding RNAs and these epigenetic signals have shown to cooperate in modulating chromatin accessibility to transcription factors and gene expression. Environmental factors such as air pollution, smoking, psychosocial context and unhealthy diet regimens have shown to significantly modify the epigenome thus leading to altered transcriptional programs and CVD phenotypes. Therefore, the integration of genetic and epigenetic information might be invaluable to build individual maps of cardiovascular risk and hence, could be employed for the design of customized diagnostic and therapeutic strategies. In the present review, we discuss the growing importance of epigenetic information and its putative implications in cardiovascular precision medicine.","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76686566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Provisional stenting or not provisional stenting: seven critical points for bifurcations treatment with a glimpse on LM bifurcation stenting. 临时支架术或不临时支架术:分枝治疗的七个关键点& LM分枝支架术的初步探讨。
Q3 Medicine Pub Date : 2020-09-30 DOI: 10.23736/S0026-4725.20.05294-9
Riccardo Iorio, A. Cereda, Augustin Vecchia, E. Romagnoli, P. Cioffi, Gaetano Chiricolo, G. Sangiorgi
Stenting of coronary bifurcation lesions represents a challenge for the interventional cardiologist. A bifurcation lesion could be treated with several techniques. Therefore, it is of paramount importance to decide the strategical approach at the beginning of the procedure evaluating the patient's bifurcation anatomy, the angle between main and side branch, plaque burden at the level of the carina, and size of the side branch. Although it is clear that all bifurcation's treatment techniques have each one their advantages and disadvantages, provisional stenting remains the gold-standard technique, because it leaves the possibility to switch to other technical solutions with optimal angiographic and long-term clinical results. In this mini-review, different tips and tricks for LM and bifurcation stenting are debated.
冠状动脉分叉病变的支架置入术对介入心脏病专家来说是一个挑战。分叉病变可以用几种技术治疗。因此,在手术开始时评估患者的分叉解剖结构、主支和侧支之间的角度、隆突水平的斑块负担和侧支的大小来决定策略入路是至关重要的。虽然很明显,所有分叉的治疗技术都有各自的优点和缺点,但临时支架置入术仍然是金标准技术,因为它有可能转换到其他具有最佳血管造影和长期临床结果的技术解决方案。在这篇简短的综述中,讨论了LM和分叉支架术的不同技巧。
{"title":"Provisional stenting or not provisional stenting: seven critical points for bifurcations treatment with a glimpse on LM bifurcation stenting.","authors":"Riccardo Iorio, A. Cereda, Augustin Vecchia, E. Romagnoli, P. Cioffi, Gaetano Chiricolo, G. Sangiorgi","doi":"10.23736/S0026-4725.20.05294-9","DOIUrl":"https://doi.org/10.23736/S0026-4725.20.05294-9","url":null,"abstract":"Stenting of coronary bifurcation lesions represents a challenge for the interventional cardiologist. A bifurcation lesion could be treated with several techniques. Therefore, it is of paramount importance to decide the strategical approach at the beginning of the procedure evaluating the patient's bifurcation anatomy, the angle between main and side branch, plaque burden at the level of the carina, and size of the side branch. Although it is clear that all bifurcation's treatment techniques have each one their advantages and disadvantages, provisional stenting remains the gold-standard technique, because it leaves the possibility to switch to other technical solutions with optimal angiographic and long-term clinical results. In this mini-review, different tips and tricks for LM and bifurcation stenting are debated.","PeriodicalId":18565,"journal":{"name":"Minerva cardioangiologica","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73072056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Minerva cardioangiologica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1